{"title":"肺部疾病生物标志物研究进展","authors":"Evan Kimber","doi":"10.33590/emjrespir/21f11019","DOIUrl":null,"url":null,"abstract":"Bringing together a collection of the most forward-thinking approaches to lung disease, the European Respiratory Society (ERS) International Congress 2021 hosted a virtual session on imaging biomarkers. Four insightful presentations discussed the shift towards more longitudinal imaging approaches for lung disease and provided an overview of quantitative analyses with computer-trained algorithms. Alongside this was a discussion of the use of novel biomarkers such as pleuroparenchymal fibroelastosis.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"85 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advances in Biomarkers for Lung Disease\",\"authors\":\"Evan Kimber\",\"doi\":\"10.33590/emjrespir/21f11019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Bringing together a collection of the most forward-thinking approaches to lung disease, the European Respiratory Society (ERS) International Congress 2021 hosted a virtual session on imaging biomarkers. Four insightful presentations discussed the shift towards more longitudinal imaging approaches for lung disease and provided an overview of quantitative analyses with computer-trained algorithms. Alongside this was a discussion of the use of novel biomarkers such as pleuroparenchymal fibroelastosis.\",\"PeriodicalId\":300382,\"journal\":{\"name\":\"EMJ Respiratory\",\"volume\":\"85 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMJ Respiratory\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33590/emjrespir/21f11019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ Respiratory","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjrespir/21f11019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Bringing together a collection of the most forward-thinking approaches to lung disease, the European Respiratory Society (ERS) International Congress 2021 hosted a virtual session on imaging biomarkers. Four insightful presentations discussed the shift towards more longitudinal imaging approaches for lung disease and provided an overview of quantitative analyses with computer-trained algorithms. Alongside this was a discussion of the use of novel biomarkers such as pleuroparenchymal fibroelastosis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
